Cart
sales@molnova.com
BDA-366
CAS No. 1909226-00-1
BDA-366( NSC-639366 | NSC639366 | BDA366 )
Catalog No. M12991 CAS No. 1909226-00-1
A potent, selective Bcl2 BH4 domain antagonist with Ki of 3.3 nM; shows no affinity for other Bcl2 family members, including Bcl-XL, Mcl-1, or Bfl-1/A1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 105 | In Stock |
|
| 10MG | 178 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 423 | In Stock |
|
| 100MG | 591 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBDA-366
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective Bcl2 BH4 domain antagonist with Ki of 3.3 nM; shows no affinity for other Bcl2 family members, including Bcl-XL, Mcl-1, or Bfl-1/A1.
-
DescriptionA potent, selective Bcl2 BH4 domain antagonist with Ki of 3.3 nM; shows no affinity for other Bcl2 family members, including Bcl-XL, Mcl-1, or Bfl-1/A1; induces apoptotic cell death in a Bax-dependent manner, and induces calcium (Ca2+) release via inhibition of Bcl2/IP3R interaction; potently represses lung cancer in vivo, and induces Bcl2 conformational change in tumor tissues.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC-639366 | NSC639366 | BDA366
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1909226-00-1
-
Formula Weight423.5
-
Molecular FormulaC24H29N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCN(CC)CC(CNC1=C2C(=C(C=C1)NCC3CO3)C(=O)C4=CC=CC=C4C2=O)O
-
Chemical Name1-(((S)-3-(diethylamino)-2-hydroxypropyl)amino)-4-((((S)-oxiran-2-yl)methyl)amino)anthracene-9,10-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Han B, et al. Cancer Cell. 2015 Jun 8;27(6):852-63.
2. Deng J, et al. Oncotarget. 2016 May 10;7(19):27753-63.
3. Vervloessem T, et al. Aging (Albany NY). 2015 Oct;7(10):748-9.
molnova catalog
related products
-
Dehydrocavidine
Dehydrocavidine has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.
-
BI-3812
A highly potent and efficacious BCL6 inhibitor that potently inhibits the interaction of the BTB/POZ domain of BCL6 with several co-repressors in vitro with IC50 of <3 nM.
-
BT2
BT2 is a BCKDC kinase (BDK) inhibitor with an IC50 of 3.19 μM. BT2 (compound 4) is also a potent and selective Mcl-1 inhibitor with a Ki value of 59 μM.
